268 related articles for article (PubMed ID: 22283765)
1. Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies.
Stan AD; Lewis DA
Curr Pharm Biotechnol; 2012 Jun; 13(8):1557-62. PubMed ID: 22283765
[TBL] [Abstract][Full Text] [Related]
2. The chandelier neuron in schizophrenia.
Lewis DA
Dev Neurobiol; 2011 Jan; 71(1):118-27. PubMed ID: 21154915
[TBL] [Abstract][Full Text] [Related]
3. Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction.
Volk DW; Lewis DA
Physiol Behav; 2002 Dec; 77(4-5):501-5. PubMed ID: 12526990
[TBL] [Abstract][Full Text] [Related]
4. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia.
Woo TU; Whitehead RE; Melchitzky DS; Lewis DA
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5341-6. PubMed ID: 9560277
[TBL] [Abstract][Full Text] [Related]
5. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia.
Lewis DA; Pierri JN; Volk DW; Melchitzky DS; Woo TU
Biol Psychiatry; 1999 Sep; 46(5):616-26. PubMed ID: 10472415
[TBL] [Abstract][Full Text] [Related]
6. [Schizophrenia and cortical GABA neurotransmission].
Hashimoto T; Matsubara T; Lewis DA
Seishin Shinkeigaku Zasshi; 2010; 112(5):439-52. PubMed ID: 20560363
[TBL] [Abstract][Full Text] [Related]
7. Selective alterations in postsynaptic markers of chandelier cell inputs to cortical pyramidal neurons in subjects with schizophrenia.
Cruz DA; Weaver CL; Lovallo EM; Melchitzky DS; Lewis DA
Neuropsychopharmacology; 2009 Aug; 34(9):2112-24. PubMed ID: 19322171
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia.
Volk DW; Pierri JN; Fritschy JM; Auh S; Sampson AR; Lewis DA
Cereb Cortex; 2002 Oct; 12(10):1063-70. PubMed ID: 12217970
[TBL] [Abstract][Full Text] [Related]
9. Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia.
Lewis DA; Hashimoto T; Morris HM
Neurotox Res; 2008 Oct; 14(2-3):237-48. PubMed ID: 19073429
[TBL] [Abstract][Full Text] [Related]
10. GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia.
Lewis DA
Brain Res Brain Res Rev; 2000 Mar; 31(2-3):270-6. PubMed ID: 10719153
[TBL] [Abstract][Full Text] [Related]
11. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects.
Pierri JN; Chaudry AS; Woo TU; Lewis DA
Am J Psychiatry; 1999 Nov; 156(11):1709-19. PubMed ID: 10553733
[TBL] [Abstract][Full Text] [Related]
12. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction.
Lewis DA; Volk DW; Hashimoto T
Psychopharmacology (Berl); 2004 Jun; 174(1):143-50. PubMed ID: 15205885
[TBL] [Abstract][Full Text] [Related]
13. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations.
Lewis DA; Moghaddam B
Arch Neurol; 2006 Oct; 63(10):1372-6. PubMed ID: 17030651
[TBL] [Abstract][Full Text] [Related]
14. Postnatal development of pre- and postsynaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex.
Cruz DA; Eggan SM; Lewis DA
J Comp Neurol; 2003 Oct; 465(3):385-400. PubMed ID: 12966563
[TBL] [Abstract][Full Text] [Related]
15. Altered cortical glutamate neurotransmission in schizophrenia: evidence from morphological studies of pyramidal neurons.
Lewis DA; Glantz LA; Pierri JN; Sweet RA
Ann N Y Acad Sci; 2003 Nov; 1003():102-12. PubMed ID: 14684438
[TBL] [Abstract][Full Text] [Related]
16. A GABAergic cortical deficit dominates schizophrenia pathophysiology.
Costa E; Davis JM; Dong E; Grayson DR; Guidotti A; Tremolizzo L; Veldic M
Crit Rev Neurobiol; 2004; 16(1-2):1-23. PubMed ID: 15581395
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the disease process of schizophrenia: the contribution of cortical GABA neurons.
Lewis DA; Hashimoto T
Int Rev Neurobiol; 2007; 78():109-31. PubMed ID: 17349859
[TBL] [Abstract][Full Text] [Related]
18. Regional specificity of chandelier neuron axon terminal alterations in schizophrenia.
Konopaske GT; Sweet RA; Wu Q; Sampson A; Lewis DA
Neuroscience; 2006; 138(1):189-96. PubMed ID: 16337746
[TBL] [Abstract][Full Text] [Related]
19. Alterations in a Unique Class of Cortical Chandelier Cell Axon Cartridges in Schizophrenia.
Rocco BR; DeDionisio AM; Lewis DA; Fish KN
Biol Psychiatry; 2017 Jul; 82(1):40-48. PubMed ID: 27884423
[TBL] [Abstract][Full Text] [Related]
20. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients.
Gluck MR; Thomas RG; Davis KL; Haroutunian V
Am J Psychiatry; 2002 Jul; 159(7):1165-73. PubMed ID: 12091195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
